Petr Charamza

Petr Charamza has a diverse work experience in the pharmaceutical industry. Petr started working at Zentiva in 2009 as a Portfolio Building specialist and continued in various roles until 2017. At Sanofi, they served as a Pricing Manager before being promoted to Global Senior Pricing & Market Access Manager at the Generics Division. From 2016 to 2017, Petr was the Global Pricing Lead for Lantus & Biosimilars. After returning to Zentiva in 2017, they assumed the positions of Head of Pricing & Market Intelligence and Head of Corporate Development Strategy.

Petr Charamza completed their Bachelor's degree in Economic Theories at Charles University from 2004 to 2006. Petr then pursued a Master's degree in Finance and Banking from Charles University from 2006 to 2009. In 2008, they attended NEOMA Business School to further their studies in Finance.